ConductScience.org, home

Paper1908882

Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.

Kabat EA and 1 other. J Immunol, 1991. Cited by 294 papers, by iCite.

Cite this record

ConductScience Library. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. Papers, record 1908882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1908882

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
PubMed
Journal
J Immunol
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
294
iCite
Relative citation ratio, by iCite
6.71
iCite
Revised in PubMed
2011-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kabat EAE A
2Wu TTT T

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody SpecificityMajor topic
Binding Sites, AntibodyMajor topic
Genes, ImmunoglobulinMajor topic
Immunoglobulin Heavy ChainsMajor topic
Immunoglobulin Light ChainsMajor topic
Immunoglobulin Variable RegionMajor topic
Amino Acid Sequence
Animals
Guinea Pigs
Humans
Mice
Molecular Sequence Data
Protein Conformation
Rabbits
Rats

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
3RO1-AI-27508NIAID NIH HHSUnited StatesR01AI027508PubMed and NIHNIH RePORTER
5RO1-AI-125616NIAID NIH HHSUnited StatesRO1AI125616PubMedNIH RePORTER

Download CSV of grants

Cited by118

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 294 citations.

PMIDTitleJournalYearIn PapersSource
42253975Engineering strategies and binding mechanisms of therapeutic anti-PD-1 antibodies approved by regulatory agencies globally.Front Immunol2026https://conductscience.org/library/papers/42253975PubMed
41310398Using phage display for rational engineering of a higher-affinity humanized 3' phosphohistidine-specific antibody.Commun Chem2025https://conductscience.org/library/papers/41310398PubMed
40864052A Novel Anti-BoNT/A Neutralizing Antibody Possessed Overlapped Epitope with SV2 and Had Prolonged Half-Life In Vivo.Toxins (Basel)2025https://conductscience.org/library/papers/40864052PubMed
40843683Guidelines in the Preparation of Fully Synthetic, Human Single-Domain Antibody Phage Display Libraries.Antibodies (Basel)2025https://conductscience.org/library/papers/40843683PubMed
39381136The process using a synthetic library that generates multiple diverse human single domain antibodies.Antib Ther2024https://conductscience.org/library/papers/39381136PubMed
39289783Sequence-based engineering of pH-sensitive antibodies for tumor targeting or endosomal recycling applications.MAbs2024https://conductscience.org/library/papers/39289783PubMed
38997490Structural Characterization of Peptide Antibodies.Methods Mol Biol2024https://conductscience.org/library/papers/38997490PubMed
38963938Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains.Glycobiology2024https://conductscience.org/library/papers/38963938PubMed
36298728Exploiting V-Gene Bias for Rapid, High-Throughput Monoclonal Antibody Isolation from Horses.Viruses2022https://conductscience.org/library/papers/36298728PubMed
36278614Yeast Surface Display Platform for Rapid Selection of an Antibody Library via Sequential Counter Antigen Flow Cytometry.Antibodies (Basel)2022https://conductscience.org/library/papers/36278614PubMed
35906512Imaging the Alternatively Spliced D Domain of Tenascin C in a Preclinical Model of Inflammatory Bowel Disease.Mol Imaging Biol2023https://conductscience.org/library/papers/35906512PubMed
35538099Profiling of hMPV F-specific antibodies isolated from human memory B cells.Nat Commun2022https://conductscience.org/library/papers/35538099PubMed
35157279Humanization of Camelid Single-Domain Antibodies.Methods Mol Biol2022https://conductscience.org/library/papers/35157279PubMed
34753944A site of vulnerability at V3 crown defined by HIV-1 bNAb M4008_N1.Nat Commun2021https://conductscience.org/library/papers/34753944PubMed
34524888
Development of a Nanobody-Based Competitive Enzyme-Linked Immunosorbent Assay for Efficiently and Specifically Detecting Antibodies against Genotype 2 Porcine Reproductive and Respiratory Syndrome Viruses.
J Clin Microbiol2021https://conductscience.org/library/papers/34524888PubMed
34390413Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method.Med Oncol2021https://conductscience.org/library/papers/34390413PubMed
33482061Chemical Diversification of Simple Synthetic Antibodies.ACS Chem Biol2021https://conductscience.org/library/papers/33482061PubMed
32991803Computational Investigation of Gantenerumab and Crenezumab Recognition of Aβ Fibrils in Alzheimer's Disease Brain Tissue.ACS Chem Neurosci2020https://conductscience.org/library/papers/32991803PubMed
32880207Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action.MAbs2020https://conductscience.org/library/papers/32880207PubMed
32640530Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs.Cancers (Basel)2020https://conductscience.org/library/papers/32640530PubMed

See all 118 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MLC123209PubTator's text mininghttps://conductscience.org/library/genes/23209

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1908882

GET https://conductscience.org/api/papers/v1/1908882/cited_by?page=2